marginally significantp = 0.066
For future metabolic risk score, BCAAs showed a marginally significant effect on metabolic syndrome risk (OR = 3.222, p = 0.066), while different results were from Hellmuth et al.'s study, which suggested tyrosine, rather than BCAAs, was the useful biomarker for future risk of IR and metabolic risk in 80 obese children with one-year follow-up.